Business
NAFDAC Blames Fake Drugs On Nigeria’s Population
The National Agency for Food and Drugs Administration and Control (NAFDAC), says Nigeria’s population has made drug counterfeiting lucrative.
The Director General, Dr Paul Orhii said this at a stakeholders meeting held with the U. S. Agency for International Development (USAID) and the U.S. Pharmacopeia in Abuja.
Orhii, who was represented by the Director, Drugs, Research and Evaluation, Mrs Hauwa Keri, said that NAFDAC as a regulatory agency was still faced with the challenge of drug counterfeiting.
He said counterfeiting can apply to both branded and generic products, and may include products with the correct ingredients with the wrong ingredients without active ingredients or otherwise, stressing that Nigeria, with a large population, heavy disease burden, good market size, and low production capacity, vast and porous borders is a prime target for counterfeiters of medicine.
“These drugs are used in high volume for managing diseases of public health interest such as anti-malarial, antibiotics, anti-hypertensive, anti-diabetic agents as well as life-style drugs,” he said.
He said that the agency had adopted a multifaceted and well coordinated strategy to ensure access to quality medicine.
“The Pharmaceutical Security Institute data estimates that drug counterfeiting is a 75 billion dollar-business, while the World Customs Service puts it at 200 billion dollars annually. “
Orhii said that with the advent of globalisation, international collaboration and cooperation was necessary in fighting drug counterfeiting to a halt.
He said that NAFDAC was working tirelessly to ensure that Nigeria’s pharmaceutical industry got World Health Organisation’s prequalification, for easy access to medicines that met unified standard of quality.
Transport
Nigeria Rates 7th For Visa Application To France —–Schengen Visa
Transport
West Zone Aviation: Adibade Olaleye Sets For NANTA President
Business
Sugar Tax ‘ll Threaten Manufacturing Sector, Says CPPE
In a statement, the Chief Executive Officer, CPPE, Muda Yusuf, said while public health concerns such as diabetes and cardiovascular diseases deserve attention, imposing an additional sugar-specific tax was economically risky and poorly suited to Nigeria’s current realities of high inflation, weak consumer purchasing power and rising production costs.
According to him, manufacturers in the non-alcoholic beverage segment are already facing heavy fiscal and cost pressures.
“The proposition of a sugar-specific tax is misplaced, economically risky, and weakly supported by empirical evidence, especially when viewed against Nigeria’s prevailing structural and macroeconomic realities.
The CPPE boss noted that retail prices of many non-alcoholic beverages have risen by about 50 per cent over the past two years, even without the introduction of new taxes, further squeezing consumers.
Yusuf further expressed reservation on the effectiveness of sugar taxes in addressing the root causes of non-communicable diseases in Nigeria.
-
News2 days agoDon Lauds RSG, NECA On Job Fair
-
Transport9 hours agoNigeria Rates 7th For Visa Application To France —–Schengen Visa
-
Niger Delta6 hours agoPDP Declares Edo Airline’s Plan As Misplaced Priority
-
Nation7 hours agoHoS Hails Fubara Over Provision of Accommodation for Permanent Secretaries
-
Niger Delta8 hours ago
Stakeholders Task INC Aspirants On Dev … As ELECO Promises Transparent, Credible Polls
-
Sports7 hours agoSimba open Nwabali talks
-
Rivers8 hours ago
Fubara Restates Continued Support For NYSC In Rivers
-
Oil & Energy9 hours agoElectricity Consumers Laud Aba Power for Exceeding 2025 Meter Rollout Target
